Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Charles M Perou

Showing results (361-370 of 447) with videos related to

Pageof 45
Sort By:
Nature|January 10, 2024
MRE11 liberates cGAS from nucleosome sequestration during tumorigenesisMin-Guk Cho, Rashmi J Kumar, Chien-Chu Lin, et al.
The Journal of Clinical Investigation|February 27, 2018
Integrated RNA and DNA sequencing reveals early drivers of metastatic breast cancerMarni B Siegel, Xiaping He, Katherine A Hoadley, et al.
Proceedings of the National Academy of Sciences of the United States of America|August 12, 2009
Residual breast cancers after conventional therapy display mesenchymal as well as tumor-initiating featuresChad J Creighton, Xiaoxian Li, Melissa Landis, et al.
JAMA Oncology|April 27, 2023
Assessment of the HER2DX Assay in Patients With ERBB2-Positive Breast Cancer Treated With Neoadjuvant Paclitaxel, Trastuzumab, and PertuzumabAdrienne G Waks, Esther R Ogayo, Laia Paré, et al.
NPJ Breast Cancer|July 20, 2017
DNA defects, epigenetics, and gene expression in cancer-adjacent breast: a study from The Cancer Genome AtlasMelissa A Troester, Katherine A Hoadley, Monica D'Arcy, et al.
Cell Reports|October 18, 2018
Cdh1 and Pik3ca Mutations Cooperate to Induce Immune-Related Invasive Lobular Carcinoma of the BreastYeji An, Jessica R Adams, Daniel P Hollern, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|July 25, 2018
Integrated Analysis of RNA and DNA from the Phase III Trial CALGB 40601 Identifies Predictors of Response to Trastuzumab-Based Neoadjuvant Chemotherapy in HER2-Positive Breast CancerMaki Tanioka, Cheng Fan, Joel S Parker, et al.
Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology|December 30, 2015
Performance of Three-Biomarker Immunohistochemistry for Intrinsic Breast Cancer Subtyping in the AMBER ConsortiumEmma H Allott, Stephanie M Cohen, Joseph Geradts, et al.
Research Square|January 3, 2024
Gene signatures derived from transcriptomic-causal networks stratified colorectal cancer patients for effective targeted therapyAkram Yazdani, Heinz-Josef Lenz, Gianluigi Pillonetto, et al.
Ebiomedicine|March 6, 2024
A 14-gene B-cell immune signature in early-stage triple-negative breast cancer (TNBC): a pooled analysis of seven studiesBenedetta Conte, Fara Brasó-Maristany, Adela Rodríguez Hernández, et al.
Pageof 45

Showing results (361-370 of 447) with videos related to

Sort By:
Pageof 45
Nature|January 10, 2024
MRE11 liberates cGAS from nucleosome sequestration during tumorigenesisMin-Guk Cho, Rashmi J Kumar, Chien-Chu Lin, et al.
The Journal of Clinical Investigation|February 27, 2018
Integrated RNA and DNA sequencing reveals early drivers of metastatic breast cancerMarni B Siegel, Xiaping He, Katherine A Hoadley, et al.
Proceedings of the National Academy of Sciences of the United States of America|August 12, 2009
Residual breast cancers after conventional therapy display mesenchymal as well as tumor-initiating featuresChad J Creighton, Xiaoxian Li, Melissa Landis, et al.
JAMA Oncology|April 27, 2023
Assessment of the HER2DX Assay in Patients With ERBB2-Positive Breast Cancer Treated With Neoadjuvant Paclitaxel, Trastuzumab, and PertuzumabAdrienne G Waks, Esther R Ogayo, Laia Paré, et al.
NPJ Breast Cancer|July 20, 2017
DNA defects, epigenetics, and gene expression in cancer-adjacent breast: a study from The Cancer Genome AtlasMelissa A Troester, Katherine A Hoadley, Monica D'Arcy, et al.
Cell Reports|October 18, 2018
Cdh1 and Pik3ca Mutations Cooperate to Induce Immune-Related Invasive Lobular Carcinoma of the BreastYeji An, Jessica R Adams, Daniel P Hollern, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|July 25, 2018
Integrated Analysis of RNA and DNA from the Phase III Trial CALGB 40601 Identifies Predictors of Response to Trastuzumab-Based Neoadjuvant Chemotherapy in HER2-Positive Breast CancerMaki Tanioka, Cheng Fan, Joel S Parker, et al.
Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology|December 30, 2015
Performance of Three-Biomarker Immunohistochemistry for Intrinsic Breast Cancer Subtyping in the AMBER ConsortiumEmma H Allott, Stephanie M Cohen, Joseph Geradts, et al.
Research Square|January 3, 2024
Gene signatures derived from transcriptomic-causal networks stratified colorectal cancer patients for effective targeted therapyAkram Yazdani, Heinz-Josef Lenz, Gianluigi Pillonetto, et al.
Ebiomedicine|March 6, 2024
A 14-gene B-cell immune signature in early-stage triple-negative breast cancer (TNBC): a pooled analysis of seven studiesBenedetta Conte, Fara Brasó-Maristany, Adela Rodríguez Hernández, et al.
Pageof 45